Clinical Trials Sponsored by Delta SA

Total 1419 results

PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII)

Uterine Fibroids

Belgium, Poland, Austria, Spain
PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)

Uterine Fibroids

Poland, Spain, Austria, Belgium
PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLext2)

Uterine Fibroids

Austria, Belgium, Poland, Spain
Telormedix SA

Completed

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Carcinoma in Situ | Non Muscle Invasive Bladder Cancer

United States
PregLem SA

Completed

PGL5001 Proof of Concept Study in Inflammatory Endometriosis (JADE)

Endometriosis

Poland
Evolva SA

Terminated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

Type 2 Diabetes

Germany
Creabilis SA

Completed

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

United States, United Kingdom
Cytheris SA

Completed

Safety Study of IL-7 in HIV-infected Patients (Inspire)

HIV Infections | Lymphopenia

United States, France, Canada, Italy
Cytheris SA

Unknown

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone (Eclipse 2)

Hepatitis C

France, Switzerland, Italy
Cytheris SA

Unknown

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy (ECLIPSE 3)

Hepatitis C

Taiwan
Xigen SA

Completed

Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers

Inflammation

Switzerland
Creabilis SA

Terminated

CT 327 in the Treatment of Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Switzerland
Noscira SA

Completed

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

Alzheimer´s Disease

Germany
Teoxane SA

Not yet recruiting

RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)

Pain | Aging

United States
Aktiia SA

Not yet recruiting

Evaluation of the Performance and Safety of the Aktiia Spot-check Optical Blood Pressure Monitoring (OBPM) Device at Fingertip (Aktiia G2C) Against Double Auscultation, and Comparison With Oscillometry and Aktiia Bracelet G2

Hypertension

Switzerland
Aktiia SA

Recruiting

Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake (OBPM_Meds2023)

Hypertension

Switzerland
Aktiia SA

Not yet recruiting

Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP (CHANGE-BP)

Hypertension

United States
Carmat SA

Recruiting

Aeson TAH System - Post-Market Clinical Follow-up Study

Heart Failure

Germany
Poxel SA

Not yet recruiting

Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)

Adrenomyeloneuropathy
Oncodesign SA

Recruiting

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients (OncoSNIPE)

CANCER

France
Carmat SA

Recruiting

Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure (EFICAS)

Advanced Heart Failure

France
Cellaion SA

Terminated

HepaStem Long-Term Safety Registry (PROLONGSTEM)

Urea Cycle Disorder | Crigler-Najjar Syndrome | Acute on Chronic Liver Failure

Belgium, Spain, France, Bulgaria, Poland
Imcyse SA

Active, not recruiting

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (IMPACT)

Diabetes Mellitus, Type 1

United Kingdom, United States, Australia, Lithuania, Belgium, Italy, Slovenia, Sweden
LimFlow SA

Active, not recruiting

Percutaneous Deep Vein Arterialization Post-Market Study (PROMISE UK)

Critical Limb Ischemia

United Kingdom
Carmat SA

Suspended

European Clinical Evaluation of the Carmat Total Artificial Heart (ADVANCEHF)

Advanced Heart Failure

Netherlands, Kazakhstan
Aktiia SA

Completed

COOL-BP Study: Continuous Versus Occasional Blood Pressure Study

Hypertension

United States
Abionic SA

Completed

Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2

COVID-19 | COVID-19 Pandemic

Italy
Remedee SA

Completed

Evaluation of the Effectiveness of the Remedee Solution in Fibromyalgia (Fibrepik)

Fibromyalgia

France
Sintetica SA

Completed

Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.

Cataract

Italy, Slovakia, Spain
Teoxane SA

Active, not recruiting

TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Skin Aging | Fine Lines of the Face and Neck

Spain
Cardiawave SA

Completed

A Prospective RegistrY of Cardiac Echographic Loops (ARYEL)

Calcified Aortic Valve

France
ObsEva SA

Completed

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF (IMPLANT4)

Infertility

Belgium, Canada, Czechia, Denmark, Estonia, Germany, Hungary, Poland, Russian Federation, Spain
ObsEva SA

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 1)

Uterine Fibroids | Heavy Menstrual Bleeding

United States
Aspivix SA

Completed

Usability, Safety and Efficacy of AspivixTM

IUD Insertion

Switzerland
Ixaltis SA

Completed

DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence

Urinary Incontinence

United States
Mabion SA

Completed

MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Serbia, Poland, Bosnia and Herzegovina, Georgia, Ukraine
Axalbion SA

Completed

AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects

Healthy

United Kingdom
Imcyse SA

Completed

Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom, Belgium, Denmark, Germany, Lithuania, Sweden, France
Celergan SA

Completed

Efficacy and Tolerability of CELERGEN in Fibromyalgia

Fibromyalgia

Spain
Poxel SA

Completed

Pharmacokinetics and Metabolism of (14C)-Labelled PXL770

Healthy

United Kingdom
Poxel SA

Completed

Bioequivalence of Imeglimin Tablet Formulations

Bioequivalence

United Kingdom
Him SA

Completed

SMARTCARE Project: Deploying Integrated Health & Social Services for Independent Living by Older People (SmartCare)

Frail Elderly Syndrome | Congestive Heart Failure | Falls Prevention
Mindmaze SA

Terminated

Study Evaluating the MindMotionPRO for Early Post-stroke Upper-limb Rehabilitation (MOVE-Rehab)

Stroke | Motor Disorders

Germany, Italy, United Kingdom
ObsEva SA

Terminated

A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth (TERM)

Preterm Labor

Poland, United Kingdom, Spain, Switzerland, Belgium, Germany
Poxel SA

Completed

Safety, Tolerability and PK of Imeglimin in Japanese Volunteers

Type 2 Diabetes Mellitus

United Kingdom
Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain

Pain | Inflammation | Cataract

United States
Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Pain | Inflammation | Cataract

United States
Teoxane SA

Completed

TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

Crow's Feet Wrinkles

Switzerland
Luzitin SA

Unknown

Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer

Head and Neck Cancer

Portugal
Creabilis SA

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Atopic Dermatitis

United Kingdom

3

Subscribe